Hyaluronic acid modified Cu/Mn-doped metal-organic framework nanocatalyst for chemodynamic therapy DOI

Xiaohuan Guo,

Q. Fang,

Nan Leng

и другие.

Biomedical Materials, Год журнала: 2024, Номер 19(6), С. 065025 - 065025

Опубликована: Окт. 2, 2024

Chemodynamic therapy (CDT) is a new method for cancer treatment that produces highly toxic reactive oxygen species (ROS) in the tumor microenvironment to induce cell apoptosis or necrosis. However, therapeutic effect of CDT often hindered by intracellular H

Язык: Английский

Metal‐Protein Hybrid Materials: Unlocking New Frontiers in Biomedical Applications DOI Open Access
Yong Pan, Han Zhao, Wenyong Huang

и другие.

Advanced Healthcare Materials, Год журнала: 2025, Номер unknown

Опубликована: Янв. 7, 2025

Abstract Metal‐protein hybrid materials represent a novel class of functional that exhibit exceptional physicochemical properties and tunable structures, rendering them remarkable applications in diverse fields, including engineering, biocatalysis, biosensing, biomedicine. The design development multifunctional biocompatible metal‐protein have been the subject extensive research key aspiration for practical clinical settings. This review provides comprehensive analysis strategies, intrinsic properties, biomedical these materials, with specific emphasis on their potential cancer therapy, drug vaccine delivery, antibacterial treatments, tissue regeneration. Through rational design, stable can be synthesized using straightforward methods, enabling therapeutic, immunomodulatory, other desired functionalities. Finally, outlines existing limitations challenges associated evaluates translation, providing insights into implementation within applications.

Язык: Английский

Процитировано

3

Phototherapy: progress, challenges, and opportunities DOI
Xi Yuan,

Junliang Zhou,

Lin Yuan

и другие.

Science China Chemistry, Год журнала: 2024, Номер unknown

Опубликована: Дек. 5, 2024

Язык: Английский

Процитировано

16

A proton pump inhibitor-programmed ROS generator enhances the synergistic efficacy of chemo-/chemodynamic therapy with reduced renal injury DOI
Jiaxuan Li, Yanqing Li, Yi Wang

и другие.

Chemical Engineering Journal, Год журнала: 2025, Номер unknown, С. 159201 - 159201

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

1

Glutathione depletion-based pH-responsive injectable hydrogels for synergistic treatment of colon tumor DOI
Xinyuan Zhang, Yu Li, Yanhui Zhang

и другие.

International Journal of Biological Macromolecules, Год журнала: 2025, Номер 297, С. 139557 - 139557

Опубликована: Янв. 6, 2025

Язык: Английский

Процитировано

1

Nanocatalytic Medicine Enabled Next-Generation Therapeutics for Bacterial Infections DOI Creative Commons
Min Ge, Feng Jiang, Han Lin

и другие.

Materials Today Bio, Год журнала: 2024, Номер 29, С. 101255 - 101255

Опубликована: Сен. 17, 2024

Язык: Английский

Процитировано

5

Mixed-valence vanadium-doped mesoporous bioactive glass for treatment of tumor-associated bone defects DOI
Xin Liu, Pengfei Zhang,

Mengjie Xu

и другие.

Journal of Materials Chemistry B, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Vanadium is a bioactive trace element with variable valence. Its pentavalent form has been confirmed to be capable of predominantly regulating the early and mid-stage osteogenic differentiation bone marrow mesenchymal stem cells (BMSCs) without tumor inhibition, while its tetravalent exhibits inhibition but only primarily modulates late angiogenesis. In this study, multifunctional tissue scaffold consisting mixed-valence vanadium-doped mesoporous glass poly(lactic-co-glycolic acid) (V(IV/V)-MBG/PLGA) was developed simultaneously inhibit recurrence osteosarcoma promote regeneration operative defects. The in vitro results showed that V(IV) V(V) species could sustainably released from V(IV/V)-MBG complementarily enhance proliferation, differentiation, mineralization BMSCs by activating multiple signaling pathways throughout whole osteogenesis process. More importantly, co-existence mixed-valent vanadium able continuously stimulate generation excessive ROS depletion GSH synergistically supplying an appropriate ratio thermodynamically kinetically maintain stable self-circulation valence state alteration, thus inducing UMR-106 cell death. rat model, V(IV/V)-MBG/PLGA scaffolds effectively suppressed invasion promoted regeneration. These suggest are promising strategy for treating tumor-associated defects, offering dual

Язык: Английский

Процитировано

0

Injectable Magnetic-Nanozyme Based Thermosensitive Hydrogel for Multimodal DLBCL Therapy DOI Creative Commons

Min Yan,

Jingcui Peng,

Haoan Wu

и другие.

Gels, Год журнала: 2025, Номер 11(3), С. 218 - 218

Опубликована: Март 20, 2025

Diffuse large B-cell lymphoma (DLBCL), accounting for 31% of non-Hodgkin lymphomas, remains recalcitrant to conventional therapies due chemoresistance, metastatic progression, and immunosuppressive microenvironments. We report a novel injectable Fe3O4@DMSA@Pt@PLGA-PEG-PLGA hydrogel system integrating magnetothermal therapy (MHT), chemodynamic (CDT), immunomodulation. Under alternating magnetic fields (AMF), the achieves rapid therapeutic hyperthermia (50 °C within 7 min) while activating pH/temperature-dual responsive peroxidase (POD) -like activity in Fe3O4@DMSA@Pt nanoparticles. Catalytic efficiency under tumor-mimetic conditions was significantly higher than Fe3O4@DMSA controls, generating elevated reactive oxygen species (ROS). Flow cytometry revealed 75.9% apoptotic cell death A20 cells at 50 °C, surpassing CDT alone (24.5%). Importantly, this dual mechanism induced immunogenic (ICD) characterized by 4.1-fold CRT externalization, 68% HMGB1 nuclear depletion, 40.74 nM ATP secretion. This triggered robust dendritic maturation (92% CD86+/CD80+ DCs comparable LPS controls) T activation (16.9% CD25+/CD69+ ratio, 130-fold baseline). Our findings validate potential magnetothermal-chemodynamic synergy DLBCL treatment, paving way innovative multi-mechanism strategies against with clinical translation prospects.

Язык: Английский

Процитировано

0

Metal-based nanomedicine systems for the diagnosis and treatment of colorectal cancer: Current advances and future perspectives DOI

Jie Gou,

Lu Chen,

Tianyu Liu

и другие.

Materials Today Chemistry, Год журнала: 2025, Номер 45, С. 102702 - 102702

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Elongated Magnetic Nanorobots with Multi-Enzymatic Cascades for Active In Vivo Tumor Targeting and Enhanced Chemodynamic Therapy DOI
Diyan Li, Chi Zhang, Qirong Xiong

и другие.

ACS Nano, Год журнала: 2025, Номер unknown

Опубликована: Апрель 14, 2025

Targeted delivery of therapeutic agents to malignant tissues is crucial for enhancing clinical outcomes and reducing side effects. Magnetic nanorobots (MNRs) present a promising strategy controlled delivery, leveraging external magnetic fields achieve precise in vivo targeting. This work develops elongated MNRs comprising linearly arranged nanoparticles linked by metal-polyphenol complexes (MPCs) magnetic-field-directed active tumor targeting synergistic therapy. The are created assembling 30 nm Fe3O4 nanoparticles, tannic acid, ferrous ions (Fe2+) under uniform field, resulting chain-like structures fixed MPCs, which also promotes peroxidase-like activity. These show greater response than individual offering flexibility manipulation. MPCs coating allows tailored surface modifications with glucose oxidase, copper (Cu2+), human serum albumin (HSA), producing colloidally stable built-in multienzymatic cascade (MNRs@GOx/Cu/HSA) that consumes glucose, generates •OH, depletes the antioxidant glutathione (GSH). Collectively, surface-engineered multifunctional demonstrate improved driven fields, leading efficient localized chemodynamic structural functional properties developed render them suitable targeted cargo minimally invasive surgery, treatments disease sites.

Язык: Английский

Процитировано

0

Enhanced sequential osteosarcoma therapy using a 3D-Printed bioceramic scaffold combined with 2D nanosheets via NIR-II photothermal-chemodynamic synergy DOI
Guangyu Jian, Si Wang, Xinlu Wang

и другие.

Bioactive Materials, Год журнала: 2025, Номер 50, С. 540 - 555

Опубликована: Май 1, 2025

Язык: Английский

Процитировано

0